SCHRODINGER INC (SDGR) Fundamental Analysis & Valuation

NASDAQ:SDGR • US80810D1037

12.73 USD
+0.1 (+0.79%)
At close: Mar 11, 2026
12.3471 USD
-0.38 (-3.01%)
After Hours: 3/11/2026, 8:24:40 PM

This SDGR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

Taking everything into account, SDGR scores 4 out of 10 in our fundamental rating. SDGR was compared to 35 industry peers in the Health Care Technology industry. No worries on liquidiy or solvency for SDGR as it has an excellent financial health rating, but there are worries on the profitability. SDGR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. SDGR Profitability Analysis

1.1 Basic Checks

  • In the past year SDGR has reported negative net income.
  • In the past year SDGR had a positive cash flow from operations.
  • SDGR had negative earnings in 4 of the past 5 years.
  • In the past 5 years SDGR reported 4 times negative operating cash flow.
SDGR Yearly Net Income VS EBIT VS OCF VS FCFSDGR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50M -100M -150M -200M

1.2 Ratios

  • With a Return On Assets value of -14.22%, SDGR perfoms like the industry average, outperforming 54.29% of the companies in the same industry.
  • With a Return On Equity value of -28.37%, SDGR perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
Industry RankSector Rank
ROA -14.22%
ROE -28.37%
ROIC N/A
ROA(3y)-10.63%
ROA(5y)-13.36%
ROE(3y)-21.78%
ROE(5y)-23.34%
ROIC(3y)N/A
ROIC(5y)N/A
SDGR Yearly ROA, ROE, ROICSDGR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20 -30 -40

1.3 Margins

  • SDGR's Gross Margin of 55.74% is in line compared to the rest of the industry. SDGR outperforms 45.71% of its industry peers.
  • SDGR's Gross Margin has been stable in the last couple of years.
  • SDGR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.04%
GM growth 5Y-1.04%
SDGR Yearly Profit, Operating, Gross MarginsSDGR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

7

2. SDGR Health Analysis

2.1 Basic Checks

  • SDGR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • SDGR has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, SDGR has more shares outstanding
  • SDGR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SDGR Yearly Shares OutstandingSDGR Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
SDGR Yearly Total Debt VS Total AssetsSDGR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • SDGR has an Altman-Z score of 0.47. This is a bad value and indicates that SDGR is not financially healthy and even has some risk of bankruptcy.
  • SDGR has a Altman-Z score (0.47) which is in line with its industry peers.
  • There is no outstanding debt for SDGR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 0.47
ROIC/WACCN/A
WACC9.38%
SDGR Yearly LT Debt VS Equity VS FCFSDGR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • SDGR has a Current Ratio of 2.75. This indicates that SDGR is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 2.75, SDGR is doing good in the industry, outperforming 65.71% of the companies in the same industry.
  • A Quick Ratio of 2.75 indicates that SDGR has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 2.75, SDGR is in the better half of the industry, outperforming 68.57% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.75
Quick Ratio 2.75
SDGR Yearly Current Assets VS Current LiabilitesSDGR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

6

3. SDGR Growth Analysis

3.1 Past

  • SDGR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45.14%, which is quite impressive.
  • The Revenue has grown by 23.29% in the past year. This is a very strong growth!
  • The Revenue has been growing by 18.81% on average over the past years. This is quite good.
EPS 1Y (TTM)45.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%181.82%
Revenue 1Y (TTM)23.29%
Revenue growth 3Y12.23%
Revenue growth 5Y18.81%
Sales Q2Q%-1.23%

3.2 Future

  • Based on estimates for the next years, SDGR will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.89% on average per year.
  • Based on estimates for the next years, SDGR will show a very strong growth in Revenue. The Revenue will grow by 26.73% on average per year.
EPS Next Y-30.27%
EPS Next 2Y6.26%
EPS Next 3Y24.76%
EPS Next 5Y19.89%
Revenue Next Year5.57%
Revenue Next 2Y6.62%
Revenue Next 3Y15.71%
Revenue Next 5Y26.73%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SDGR Yearly Revenue VS EstimatesSDGR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B
SDGR Yearly EPS VS EstimatesSDGR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -1 -2

1

4. SDGR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for SDGR. In the last year negative earnings were reported.
  • Also next year SDGR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SDGR Price Earnings VS Forward Price EarningsSDGR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of SDGR is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 75.45
EV/EBITDA N/A
SDGR Per share dataSDGR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as SDGR's earnings are expected to grow with 24.76% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.26%
EPS Next 3Y24.76%

0

5. SDGR Dividend Analysis

5.1 Amount

  • No dividends for SDGR!.
Industry RankSector Rank
Dividend Yield 0%

SDGR Fundamentals: All Metrics, Ratios and Statistics

SCHRODINGER INC

NASDAQ:SDGR (3/11/2026, 8:24:40 PM)

After market: 12.3471 -0.38 (-3.01%)

12.73

+0.1 (+0.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-25
Earnings (Next)05-05
Inst Owners107.63%
Inst Owner Change-0.61%
Ins Owners2.63%
Ins Owner Change-0.18%
Market Cap939.86M
Revenue(TTM)255.87M
Net Income(TTM)-103.27M
Analysts82.67
Price Target25.95 (103.85%)
Short Float %17.06%
Short Ratio7.86
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)188.66%
Min EPS beat(2)37.55%
Max EPS beat(2)339.77%
EPS beat(4)3
Avg EPS beat(4)98.63%
Min EPS beat(4)-7.46%
Max EPS beat(4)339.77%
EPS beat(8)6
Avg EPS beat(8)49.47%
EPS beat(12)8
Avg EPS beat(12)42.81%
EPS beat(16)11
Avg EPS beat(16)35.01%
Revenue beat(2)2
Avg Revenue beat(2)2.93%
Min Revenue beat(2)2.55%
Max Revenue beat(2)3.3%
Revenue beat(4)4
Avg Revenue beat(4)3.98%
Min Revenue beat(4)2.55%
Max Revenue beat(4)6.83%
Revenue beat(8)6
Avg Revenue beat(8)1.09%
Revenue beat(12)7
Avg Revenue beat(12)-0.01%
Revenue beat(16)11
Avg Revenue beat(16)4.95%
PT rev (1m)1.78%
PT rev (3m)-6.53%
EPS NQ rev (1m)-5.31%
EPS NQ rev (3m)-12.62%
EPS NY rev (1m)-16.41%
EPS NY rev (3m)-17.53%
Revenue NQ rev (1m)-18.34%
Revenue NQ rev (3m)-16.65%
Revenue NY rev (1m)-11.57%
Revenue NY rev (3m)-12.2%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.67
P/FCF 75.45
P/OCF 67.62
P/B 2.58
P/tB 2.62
EV/EBITDA N/A
EPS(TTM)-1.41
EYN/A
EPS(NY)-1.84
Fwd EYN/A
FCF(TTM)0.17
FCFY1.33%
OCF(TTM)0.19
OCFY1.48%
SpS3.47
BVpS4.93
TBVpS4.87
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -14.22%
ROE -28.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 55.74%
FCFM 4.87%
ROA(3y)-10.63%
ROA(5y)-13.36%
ROE(3y)-21.78%
ROE(5y)-23.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.04%
GM growth 5Y-1.04%
F-Score5
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 23.95%
Cap/Sales 0.56%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.75
Quick Ratio 2.75
Altman-Z 0.47
F-Score5
WACC9.38%
ROIC/WACCN/A
Cap/Depr(3y)128.02%
Cap/Depr(5y)164.04%
Cap/Sales(3y)3.42%
Cap/Sales(5y)3.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%181.82%
EPS Next Y-30.27%
EPS Next 2Y6.26%
EPS Next 3Y24.76%
EPS Next 5Y19.89%
Revenue 1Y (TTM)23.29%
Revenue growth 3Y12.23%
Revenue growth 5Y18.81%
Sales Q2Q%-1.23%
Revenue Next Year5.57%
Revenue Next 2Y6.62%
Revenue Next 3Y15.71%
Revenue Next 5Y26.73%
EBIT growth 1Y20.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year18.11%
EBIT Next 3Y22.46%
EBIT Next 5YN/A
FCF growth 1Y107.56%
FCF growth 3YN/A
FCF growth 5Y-2.61%
OCF growth 1Y108.83%
OCF growth 3YN/A
OCF growth 5Y-3.67%

SCHRODINGER INC / SDGR FAQ

What is the ChartMill fundamental rating of SCHRODINGER INC (SDGR) stock?

ChartMill assigns a fundamental rating of 4 / 10 to SDGR.


What is the valuation status for SDGR stock?

ChartMill assigns a valuation rating of 1 / 10 to SCHRODINGER INC (SDGR). This can be considered as Overvalued.


What is the profitability of SDGR stock?

SCHRODINGER INC (SDGR) has a profitability rating of 1 / 10.